Milton Pharmaceutical Company is widely recognised as leading experts in all aspects of pharmaceutical formulation development and dosage form optimisation for a wide range of product types including those that have poor solubility or bioavailability. We also have knowledge and expertise in the formulation development of modified or targeted release within the body. Our professional expertise is underpinned by a comprehensive selection of supporting technologies, and all prototype formulations undergo extensive screening and stability evaluation in a non-GMP environment.
Once Milton Pharmaceutical Company have investigated the fundamental properties of a drug, we can prepare a formulation development strategy to bring it rapidly and effectively to First in Man (FIM) studies and on towards clinical use. The formulations we create are designed to precisely match our clients’ requirements and resources. Significantly, they are provided royalty-free so there is no commitment or limiting factor on any future development. Our work is carried out on a purely fee-for-service basis, with our aim simply to provide the best formulation development and the best chance of clinical success. A large suite of formulation development services are offered at Milton Pharmaceutical Company, which include:
Oral Dosage Forms, Formulation Development:
- Immediate release and controlled release tablets
- Multilayer tablets
- Immediate release capsules
- Oral multiparticulates such as beads, pellets and mini-tablets
- Liquid and semi-solid filled capsules
- Fast dispersible tablets
- Coating of tablets, capsules and pellets
- Micro-encapsulation using spray drying
- Oral liquids and suspensions
- Non-sterile, live bacteria for oral delivery
Other Formulation Development Dosage Forms
- Liquids and semi-solids for topical delivery, such as creams, ointments, lotions and gels
- Parenteral formulations for early phase toxicity evaluation
- Buccal delivery
- Nasal sprays
- Dental products